Metropolitan Life Insurance Company (MetLife)’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,437
Closed -$125K 1486
2024
Q1
$125K Sell
8,437
-1,076
-11% -$14.7K 0.01% 931
2023
Q4
$87K Hold
9,513
﹤0.01% 1160
2023
Q3
$53K Buy
9,513
+993
+12% +$6.95K ﹤0.01% 1369
2023
Q2
$68.7K Buy
8,520
+3,323
+64% +$24.5K ﹤0.01% 1232
2023
Q1
$34K Sell
5,197
-2,391
-32% -$9.76K ﹤0.01% 1606
2022
Q4
$18.7K Hold
7,588
﹤0.01% 2051
2022
Q3
$37.9K Hold
7,588
﹤0.01% 1641
2022
Q2
$32.2K Buy
+7,588
New +$48.3K ﹤0.01% 1777

Other funds holding OSCR

Metropolitan Life Insurance Company (MetLife)'s OSCR Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Oscar Health (OSCR) in Q2 2024, closing a stake of 8,437 shares — an estimated $125K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in OSCR in Q2 2022 and held it in 8 quarters. The position peaked at $125K in Q1 2024. 261 funds tracked by Wall St. Rank hold OSCR as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Oscar Health position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 8,437 Oscar Health shares in Q2 2024, an estimated $125K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Oscar Health in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Oscar Health position peaked at $125K in Q1 2024.
  • 261 funds tracked by Wall St. Rank held Oscar Health as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.